| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.420 | None | 1.000 | 5 | 1 | 1998 | 2018 | ||||||||
|
cyclin dependent kinase like 5 | 0.522 | 0.692 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
polynucleotide kinase 3'-phosphatase | 0.553 | 0.692 | 3.7E-14 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
solute carrier family 12 member 5 | 0.570 | 0.654 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
solute carrier family 6 member 1 | 0.592 | 0.538 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class M | 0.695 | 0.346 | 5.4E-05 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
parvalbumin | 0.547 | 0.692 | 8.7E-02 |
|
phenotype | 0.320 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
phenotype | 0.310 | None | 1.000 | 4 | 0 | 1989 | 2010 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
phenotype | 0.310 | None | 1.000 | 4 | 0 | 2004 | 2018 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
phenotype | 0.310 | None | 1.000 | 3 | 0 | 1991 | 2007 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
phenotype | 0.300 | None | 1.000 | 6 | 0 | 1991 | 2000 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 6 | 0 | 1982 | 1991 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
phenotype | 0.300 | None | 1.000 | 6 | 0 | 1970 | 2009 | ||||||||
|
cholinergic receptor nicotinic alpha 7 subunit | 0.532 | 0.654 | 4.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 1998 | 2004 | ||||||||
|
cholinergic receptor muscarinic 1 | 0.653 | 0.577 | 0.99 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 1994 | 2003 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 1996 | 2003 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1997 | 2011 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1996 | 2011 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1991 | 2002 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1994 | 2010 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2008 | 2011 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2010 | ||||||||
|
thyrotropin releasing hormone | 0.519 | 0.846 | 8.9E-04 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1999 | 2005 |